Since the ECDC and EFSA joint rapid outbreak assessment was published on 7 March 2017, six EU Member States (Belgium, France, Italy, Norway, Sweden and the United Kingdom) have reported 50 confirmed and 12 probable new cases associated with the multi-country outbreak of Salmonella Enteritidis phage type 8 infections (MLVA profiles 2-9-7-3-2 and 2-9-6-3-2) ongoing in the EU/EEA. In addition, twelve probable cases have been reclassified as confirmed.
ECDC Director Marc Sprenger addressed MEPs of the European Parliament’s Committee on the Environment, Public Health and Food Safety regarding the ongoing Ebola virus disease outbreak in West Africa.
ECDC is supporting a large number of targeted External Quality Assessment (EQA) schemes with voluntary participation by reference or primary laboratories, which are active members of EU surveillance networks
ECDC promotes the performance of external quality assessment (EQA) schemes, in which laboratories are sent simulated clinical specimens or bacterial isolates for testing by routine or reference laboratory methods. EQA schemes, or laboratory proficiency testing, provide information about the accuracy of different characterisation and typing methods as well as antimicrobial susceptibility testing (AST) and the sensitivity of the methods in place to detect a certain pathogen or novel resistance patterns.
This workshop on AMR in Salmonella and Campylobacter was arranged in cooperation with the FWD Network and the EU reference laboratory for antimicrobial resistance network.
An outbreak of S. Enteritidis phage type 8 is ongoing in the EU/EEA. Isolates are part of two distinct but related genetic clusters. ECDC and EFSA are liaising with relevant authorities to facilitate the coordination of investigation response measures.
European Union summary report based on data on antimicrobial resistance in zoonotic and indicator bacteria in 2015, submitted by 28 EU Member States (MSs), jointly analysed by EFSA and ECDC.
This rapid risk assessment assesses the recurrent multi-country outbreak of Salmonella Enteritidis due to a persistent source of infection, with current or recent exposure in at least four EU/EEA Member States.